Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 87501-87550 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04833790
What Drives Poor Care for Child Diarrhea: A Standardized Patient Experiment
NAActive, not recruiting
2,451 participants
Started: May 5, 2022 · Completed: Jun 1, 2025
1 condition1 sponsor1 location
NCT05548712
The Effect of PEMF for Patients With Knee OA
NARecruiting
80 participants
Started: May 5, 2022 · Completed: Sep 15, 2024
2 conditions1 sponsor1 location
NCT05337137
A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer
PHASE1/PHASE2Active, not recruiting
162 participants
Started: May 5, 2022 · Completed: Nov 7, 2025
1 condition1 sponsor61 locations
NCT05741814
Propofol Sedation vs. Anaesthetist Guided Anaesthesia in Oocyte Pickup
NARecruiting
100 participants
Started: May 5, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04644289
WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC
PHASE2Recruiting
60 participants
Started: May 5, 2022 · Completed: Jun 30, 2028
1 condition1 sponsor6 locations
NCT05040360
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
PHASE2Recruiting
141 participants
Started: May 5, 2022 · Completed: Mar 31, 2027
5 conditions2 sponsors319 locations
NCT04732416
HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI)
PHASE2Recruiting
16 participants
Started: May 5, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor7 locations
NCT05354323
NECVAX-NEO1 in Addition to Checkpoint Inhibitor in Patients With Solid Tumors
PHASE1Active, not recruiting
6 participants
Started: May 5, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor3 locations
NCT05775029
RSI Observation Follow-up
N/AActive, not recruiting
2,300 participants
Started: May 5, 2022 · Completed: Jun 1, 2025
4 conditions1 sponsor2 locations
NCT06724471
Preservation of Women's Fertility: Evaluation of Innovative Methods for Ovarian Tissue Cryopreservation
N/AActive, not recruiting
30 participants
Started: May 5, 2022 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT05225363
Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer
PHASE1Recruiting
33 participants
Started: May 5, 2022 · Completed: Jun 5, 2027
1 condition2 sponsors1 location
NCT05395325
Clinical Effects of Combined Kinesiotaping and Steroid Injection in Stroke Patients With Hemiplegic Shoulder Pain
NARecruiting
50 participants
Started: May 5, 2022 · Completed: Aug 31, 2024
2 conditions1 sponsor1 location
NCT05416879
Lifestyle Behaviours of Women Newly Diagnosed With Heart Failure
N/ARecruiting
40 participants
Started: May 5, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05371626
Cicatricial Upper Eyelid Entropion Management
NARecruiting
30 participants
Started: May 5, 2022 · Completed: Jun 1, 2024
1 condition1 sponsor1 location
NCT05369845
Observance of Continuous Positive Pressure for the Treatment of Obstructive Sleep Apnea Syndrome
NAActive, not recruiting
132 participants
Started: May 5, 2022 · Completed: Jun 30, 2026
4 conditions1 sponsor1 location
NCT05171049
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
PHASE3Active, not recruiting
1,150 participants
Started: May 5, 2022 · Completed: Feb 28, 2027
3 conditions2 sponsors209 locations
NCT04976036
Efficacy of Nintedanib for Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Patients
PHASE2Recruiting
48 participants
Started: May 5, 2022 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT05339932
Grand Valley State University (GVSU) Skills on Wheels
NAActive, not recruiting
4 participants
Started: May 5, 2022 · Completed: Dec 31, 2027
6 conditions1 sponsor1 location
NCT05550246
Identifying Sleep Apnea Patients That Best Respond to Atomoxetine Plus Oxybutynin Therapy
PHASE1/PHASE2Recruiting
22 participants
Started: May 5, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05267041
Joint Thoracic Oncology Research Unit of LYon: Lung CancerS DatabaSE (ULYSSE)
NARecruiting
4,000 participants
Started: May 5, 2022 · Completed: May 5, 2042
1 condition1 sponsor1 location
NCT06160479
The Incidence of Hypocalcemia in Pregnant Women at Siriraj Hospital
NAActive, not recruiting
444 participants
Started: May 5, 2022 · Completed: May 31, 2024
1 condition1 sponsor1 location
NCT05221359
Pilot Study Evaluating Safety of ExOlin® in Patients With Poorly Controlled Type 1 Diabetes
NARecruiting
8 participants
Started: May 5, 2022 · Completed: Apr 30, 2027
2 conditions1 sponsor1 location
NCT05349331
Watch and Wait and Surgical Treatment for Clinical Complete Responders After Non-Curative Therapy for Hepatocellular Carcinoma
PHASE2Active, not recruiting
74 participants
Started: May 5, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05090891
To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva
PHASE2Recruiting
98 participants
Started: May 5, 2022 · Completed: Dec 23, 2032
1 condition1 sponsor27 locations
NCT05151120
Harmonization of Thyroid-stimulating Hormone Immunoassays Reagents
N/ARecruiting
100 participants
Started: May 5, 2022 · Completed: May 5, 2026
2 conditions1 sponsor2 locations
NCT05017935
RADIANCE Continued Access Protocol
NAActive, not recruiting
300 participants
Started: May 4, 2022 · Completed: Dec 31, 2028
4 conditions1 sponsor40 locations
NCT05078164
Preventing Firearm Violence in Youth: A Hospital-based Prevention Strategy
NARecruiting
300 participants
Started: May 4, 2022 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT05431361
PRehab tO PreparE Living Liver Donors for Enhanced Recovery
NAActive, not recruiting
30 participants
Started: May 4, 2022 · Completed: Dec 12, 2024
1 condition1 sponsor1 location
NCT05973981
The Impact of Standardized Tobacco Product Packaging on Young Adults in the Retail Environment
NARecruiting
900 participants
Started: May 4, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05140434
Evaluation of the Benefit of Exercise Testing for the Diagnosis of Obstruction in the Coronary Arteries of the Heart
N/ARecruiting
120 participants
Started: May 4, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06128148
Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid Tumors
PHASE1Recruiting
101 participants
Started: May 4, 2022 · Completed: Dec 30, 2027
4 conditions1 sponsor1 location
NCT05103436
Electrical Stimulation for Spasticity in Spinal Cord Injury
NAActive, not recruiting
40 participants
Started: May 4, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05807256
Medically Assisted Fertilization Techniques in Systemic Immunoreumatologic Diseases
N/ARecruiting
500 participants
Started: May 4, 2022 · Completed: Nov 30, 2025
5 conditions1 sponsor1 location
NCT05347771
Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents
PHASE2Recruiting
240 participants
Started: May 4, 2022 · Completed: Dec 15, 2025
1 condition4 sponsors8 locations
NCT05371964
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Imetelstat in Combination With Ruxolitinib in Participants With Myelofibrosis
PHASE1Recruiting
51 participants
Started: May 4, 2022 · Completed: Aug 31, 2028
1 condition1 sponsor8 locations
NCT05365672
Clinical Trial With Donor Modified Immune Cells in Living Donor Kidney Transplantation
PHASE2Recruiting
126 participants
Started: May 4, 2022 · Completed: Dec 31, 2028
1 condition2 sponsors8 locations
NCT05085171
An Enhanced Package of Care to Reduce Reduce Mortality in Advanced HIV Disease
PHASE3Recruiting
2,400 participants
Started: May 4, 2022 · Completed: Sep 1, 2027
1 condition2 sponsors1 location
NCT05344703
Is Y-Balance Test Predictive of Concussion
NARecruiting
1,000 participants
Started: May 4, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor2 locations
NCT05179876
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option
PHASE3Recruiting
280 participants
Started: May 4, 2022 · Completed: Sep 28, 2029
1 condition1 sponsor40 locations
NCT05272631
Depuy Synthes Lower Extremity Shaft Nail Registry
N/AActive, not recruiting
250 participants
Started: May 4, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor8 locations
NCT05356182
A Pilot and Feasibility Study of a Dietary Intervention With Low-protein Meals in Cancer Patients Receiving Immunotherapies
NARecruiting
30 participants
Started: May 4, 2022 · Completed: Feb 28, 2027
3 conditions1 sponsor1 location
NCT05167695
Maintaining Behavior Change: An Evaluation of a Habit-based Sleep Health Intervention
NAActive, not recruiting
160 participants
Started: May 4, 2022 · Completed: Jul 1, 2026
1 condition1 sponsor1 location
NCT05514028
Evaluation of Salivary RNAs in the Presence of an Adnexal Mass of Ovarian Origin
N/ARecruiting
250 participants
Started: May 4, 2022 · Completed: Apr 30, 2026
3 conditions3 sponsors12 locations
NCT05285566
Pain Control for Undergoing Costal Cartilage Harvesting
PHASE4Recruiting
60 participants
Started: May 4, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT05183490
R-MVST Cells for Treatment of Viral Infections
PHASE1Recruiting
36 participants
Started: May 3, 2022 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT04904302
Sitravatinib and Nivolumab for the Treatment of Metastatic or Advanced Clear Cell Renal Cell Cancer
PHASE2Active, not recruiting
88 participants
Started: May 3, 2022 · Completed: Jan 31, 2027
3 conditions1 sponsor2 locations
NCT05269004
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis
PHASE3Active, not recruiting
1,300 participants
Started: May 3, 2022 · Completed: Dec 31, 2029
1 condition1 sponsor235 locations
NCT05398276
Behavioral Exposure for Introceptive Tolerance RCT
PHASE2Recruiting
146 participants
Started: May 3, 2022 · Completed: Jul 31, 2026
4 conditions2 sponsors2 locations
NCT05280548
A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease
PHASE3Active, not recruiting
104 participants
Started: May 3, 2022 · Completed: Dec 6, 2027
1 condition1 sponsor54 locations
NCT05159856
Early Detection of Long-term Diabetic Complications in Children and Adolescents With Type 1 Diabetes
N/ARecruiting
400 participants
Started: May 3, 2022 · Completed: Dec 31, 2025
5 conditions2 sponsors1 location